Aladhab, R. A. “Association of Empagliflozin Treatment With Changes in the Metabolic Score for Insulin Resistance in Iraqi Adults With Type 2 Diabetes: A 6-Month Prospective Cohort Study”. International Journal of Basic & Clinical Pharmacology, vol. 15, no. 5, Aug. 2026, pp. 837-43, doi:10.18203/2319-2003.ijbcp20262782.